Facebook
Twitter
LinkedIn
ForwardPULSE: Solu-Medrol as the Answer for Spinal Cord Injury? Steroids in Acute Traumatic Spinal Cord Injury_enduring
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Management of spinal cord injury in the acute phase of the trauma is still not optimal, with little advances in pharmacologic therapies over the past couple of decades. Data pertaining to the use of methylprednisolone in this patient population is still questionable given a paucity of data demonstrating efficacy of therapy. During this presentation, the current data available will discussed looking at the potential benefits and place in therapy while also weighing the risks of methylprednisolone exposure in this population.
Target Audience
Pharmacist
Learning Objectives
1. Define the pathophysiology and disease state pertaining to acute spinal cord injury
2. Describe the data for the use of methylprednisolone in acute traumatic spinal cord injury
3. Explain treatment decision making for the utilization of methylprednisolone in acute spinal cord injury based upon details pertaining to the spinal cord trauma
Additional Information
| Attachment | Size |
|---|---|
 Audience Disclosure slide_16.pptx | 460.26 KB |
 Pulse 9-20-23.docx | 16.23 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Management of spinal cord injury in the acute phase of the trauma is still not optimal, with little advances in pharmacologic therapies over the past couple of decades. Data pertaining to the use of methylprednisolone in this patient population is still questionable given a paucity of data demonstrating efficacy of therapy. During this presentation, the current data available will discussed looking at the potential benefits and place in therapy while also weighing the risks of methylprednisolone exposure in this population.
Joshua Dorazio, PharmD
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.